This finding indicates that the beneficial effects, such as hypoglycemic, hypolipidemic, and anti-inflammatory effects exerted by chrysin in this model of NAFLD, could be mediated via enhancing the expression of ACE2/Ang (1-7)/Ras receptor axis of RAS in the liver. The gene discussed is ACE2; the disease is metabolic dysfunction-associated steatotic liver disease.